First Citizens Bank & Trust Co. Increases Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

First Citizens Bank & Trust Co. boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) by 164.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 59,123 shares of the company’s stock after acquiring an additional 36,733 shares during the quarter. First Citizens Bank & Trust Co. owned 0.06% of Acadia Healthcare worth $1,464,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the stock. Verdence Capital Advisors LLC grew its position in shares of Acadia Healthcare by 3.3% in the second quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock valued at $333,000 after purchasing an additional 465 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. Public Employees Retirement System of Ohio increased its stake in Acadia Healthcare by 2.6% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock worth $691,000 after buying an additional 760 shares in the last quarter. Treasurer of the State of North Carolina raised its holdings in shares of Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares during the last quarter. Finally, Allworth Financial LP lifted its position in shares of Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC stock opened at $15.23 on Tuesday. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $45.61. The firm has a market cap of $1.41 billion, a PE ratio of 13.02, a PEG ratio of 4.33 and a beta of 0.88. The firm’s 50 day moving average price is $14.46 and its 200-day moving average price is $19.52. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million during the quarter, compared to analysts’ expectations of $852.43 million. During the same quarter last year, the firm earned $0.91 earnings per share. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several research reports. Guggenheim dropped their price target on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Jefferies Financial Group lowered shares of Acadia Healthcare to a “hold” rating in a report on Thursday. Barclays decreased their price target on shares of Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Thursday, December 4th. UBS Group dropped their price objective on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Finally, Mizuho decreased their target price on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Six research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $18.62.

Read Our Latest Stock Report on ACHC

Acadia Healthcare Company Profile

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Recommended Stories

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.